# Anticancer Mechanisms
Silymarin is the active extract of **Milk Thistle**, so the mechanisms below describe the biological actions of Milk Thistle / Silymarin / Silibinin in oncology research.
### Overview
Silymarin / Milk Thistle works across multiple cancer-relevant pathways at once. That broad activity is one reason it remains of interest as a pleiotropic adjunct rather than a single-target compound.
### 1. Apoptosis induction
* Activates both intrinsic and extrinsic apoptotic pathways
* Shifts Bcl-2/Bax balance toward cell death
* Increases caspase activation and PARP-related apoptotic signalling
### 2. Cell-cycle arrest
* Frequently induces G0/G1 arrest
* Slows replication and proliferation in multiple cancer cell lines
### 3. Anti-proliferative signalling
* Inhibits EGFR and downstream ERK1/2 signalling
* Reduces cyclin D1, survivin, c-MYC, and related growth signals
* Interferes with PI3K-linked survival pathways in selected models
### 4. Anti-angiogenic effects
* Suppresses tumour-supporting blood vessel formation
* Reduces signalling that supports tumour expansion beyond a small size
### 5. Anti-metastatic effects
* Inhibits MMP-9 and invasion-related pathways
* Reduces CXCR4 signalling
* Modulates SLIT2/ROBO1 and fibronectin-linked migration biology
### 6. NF-κB inhibition
* Reduces inflammatory and pro-survival signalling
* Interferes with tumour-promoting transcription programs
* May also weaken drug-resistance pathways
### 7. Nrf2 pathway modulation
* Acts as a flavonolignan-based Nrf2 bioactivator
* May protect healthy tissues from oxidative damage
* Requires context-specific interpretation in established tumours
### 8. ROS modulation
* Protects healthy tissue from oxidative injury in some settings
* Can also increase oxidative stress in tumour cells enough to support apoptotic death
### 9. MAPK pathway modulation
* Modulates MAPK signalling in breast and other cancer models
* Contributes to anti-proliferative and anti-metastatic activity
### 10. Emerging metabolic effects
* Emerging data suggest fasting-mimetic behaviour in hepatocellular carcinoma
* This may be relevant to metabolic oncology strategies
### 11. Hepatoprotective action
* Milk Thistle's longest-established action is liver protection
* In oncology, this can translate into lower treatment-related liver toxicity and better tolerability
### Key References
Comprehensive evaluation (2024) of silibinin anticancer activity\
Therapeutic potentials of *Silybum marianum*\
Silymarin: a promising modulator of apoptosis and survival signalling in cancer\
**Trusted product:** MCS Formulas Milk Thistle Silymarin 500mg\
500 mg Milk Thistle extract per capsule, standardised to a minimum of 80% silymarin.
Use the code `abbey5` at checkout to save 5% and help support the free Healing Cancer Study Support resources.
{% hint style="warning" %}
This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use.
{% endhint %}
{% hint style="info" %}
© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.
{% endhint %}
---
# Agent Instructions: Querying This Documentation
If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.
Perform an HTTP GET request on the current page URL with the `ask` query parameter:
```
GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/anticancer-mechanisms.md?ask=
```
The question should be specific, self-contained, and written in natural language.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.
Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.